These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 21382992

  • 21. Managing patients treated with bevacizumab combination therapy.
    Gordon MS, Cunningham D.
    Oncology; 2005; 69 Suppl 3():25-33. PubMed ID: 16301833
    [Abstract] [Full Text] [Related]

  • 22. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.
    Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH.
    N Engl J Med; 2006 Dec 14; 355(24):2542-50. PubMed ID: 17167137
    [Abstract] [Full Text] [Related]

  • 23. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab.
    Mahajan D, Miller C, Hirose K, McCullough A, Yerian L.
    J Hepatol; 2008 Nov 14; 49(5):867-70. PubMed ID: 18814928
    [Abstract] [Full Text] [Related]

  • 24. Role of bevacizumab for the treatment of non-small-cell lung cancer.
    Ramalingam S, Belani CP.
    Future Oncol; 2007 Apr 14; 3(2):131-9. PubMed ID: 17381412
    [Abstract] [Full Text] [Related]

  • 25. [Bevacizumab and arterial hypertension or proteinuria: management].
    Senellart H, Bennouna J.
    Rev Mal Respir; 2008 Jun 14; 25(6):767-72. PubMed ID: 18772832
    [Abstract] [Full Text] [Related]

  • 26. Reversible skeletal changes after treatment with bevacizumab in a child with cutaneovisceral angiomatosis with thrombocytopenia syndrome.
    Smith AR, Hennessy JM, Kurth MA, Nelson SC.
    Pediatr Blood Cancer; 2008 Sep 14; 51(3):418-20. PubMed ID: 18493993
    [Abstract] [Full Text] [Related]

  • 27. Suppression of melanoma-associated neoangiogenesis by bevacizumab.
    Jaissle GB, Ulmer A, Henke-Fahle S, Fierlbeck G, Bartz-Schmidt KU, Szurman P.
    Arch Dermatol; 2008 Apr 14; 144(4):525-7. PubMed ID: 18427047
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Anti-VEGF therapy with bevacizumab in breast cancer].
    Tóth J, Gonda A, Szántó J.
    Lege Artis Med; 2008 Oct 14; 18(10):669-73. PubMed ID: 19227609
    [Abstract] [Full Text] [Related]

  • 31. Bevacizumab in the treatment of breast cancer.
    Koutras AK, Fountzilas G, Makatsoris T, Peroukides S, Kalofonos HP.
    Cancer Treat Rev; 2010 Feb 14; 36(1):75-82. PubMed ID: 19932567
    [Abstract] [Full Text] [Related]

  • 32. Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer.
    de Gramont A, Van Cutsem E.
    Oncology; 2005 Feb 14; 69 Suppl 3():46-56. PubMed ID: 16301835
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Rupture of a cerebral arteriovenous malformation in a patient treated with bevacizumab.
    Tanvetyanon T, Murtagh R, Bepler G.
    J Thorac Oncol; 2009 Feb 14; 4(2):268-9. PubMed ID: 19179909
    [No Abstract] [Full Text] [Related]

  • 35. Bevacizumab treatment for cancer patients with cardiovascular disease: a double edged sword?
    Pereg D, Lishner M.
    Eur Heart J; 2008 Oct 14; 29(19):2325-6. PubMed ID: 18762551
    [Abstract] [Full Text] [Related]

  • 36. Bevacizumab in the treatment of metastatic colorectal cancer.
    Caprioni F, Fornarini G.
    Future Oncol; 2007 Apr 14; 3(2):141-8. PubMed ID: 17381413
    [Abstract] [Full Text] [Related]

  • 37. Bevacizumab for the treatment of advanced non-small-cell lung cancer.
    Manegold C.
    Expert Rev Anticancer Ther; 2008 May 14; 8(5):689-99. PubMed ID: 18471042
    [Abstract] [Full Text] [Related]

  • 38. Maintenance bevacizumab is associated with increased hemoglobin in patients with advanced, nonsquamous, non-small cell lung cancer.
    Riess JW, Logan AC, Krupitskaya Y, Padda S, Clément-Duchêne C, Ganjoo K, Colevas AD, Pedro-Salcedo MS, Kuo CJ, Wakelee HA.
    Cancer Invest; 2012 Mar 14; 30(3):231-5. PubMed ID: 22360362
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.